AKBA vs BCML

Comparison between Akebia Therapeutics Inc (AKBA, Company) and BayCom Corp (BCML, Company).

AKBA is from the Healthcare sector, while BCML is from the Financial Services sector.

5-Year PerformanceBCML has outperformed AKBA, delivering a return of +12.8% compared to -11.4%

AKBA vs BCML - Performance Comparison

Log

Key Characteristics

Financial metrics and valuation ratios

Metric	AKBA(COMPANY)	BCML(COMPANY)
Market Cap	$338M	$335M
Max Drawdown	99.14%	62.19%
Sharpe Ratio	-0.90	0.51
5Y Beta	1.28	0.69
Industry	Drug Manufacturers - Specialty & Generic	Banks - Regional
P/E Ratio	-16.37	12.71
Forward P/E	28.74	11.86
PEG Ratio	0.00	0.85
Dividend Yield	N/A	3.74%
5Y EPS CAGR	-35.14%	12.84%
Debt to Equity	178.59%	0.00%
Free Cash Flow Yield	17.79%	8.08%
P/S Ratio	1.45	3.50
P/B Ratio	12.49	1.00

Market Cap

Winner

AKBA

$338M

BCML

$335M

Max Drawdown

AKBA

99.14%

Winner

BCML

62.19%

Sharpe Ratio

AKBA

-0.90

Winner

BCML

0.51

5Y Beta

AKBA

1.28

Winner

BCML

0.69

Industry

AKBA

Drug Manufacturers - Specialty & Generic

BCML

Banks - Regional

P/E Ratio

Winner

AKBA

-16.37

BCML

12.71

Forward P/E

AKBA

28.74

Winner

BCML

11.86

PEG Ratio

Winner

AKBA

0.00

BCML

0.85

Dividend Yield

AKBA

N/A

BCML

3.74%

5Y EPS CAGR

AKBA

-35.14%

Winner

BCML

12.84%

Debt to Equity

AKBA

178.59%

Winner

BCML

0.00%

Free Cash Flow Yield

Winner

AKBA

17.79%

BCML

8.08%

P/S Ratio

Winner

AKBA

1.45

BCML

3.50

P/B Ratio

AKBA

12.49

Winner

BCML

1.00

AKBA vs BCML - Historical Returns

Returns include dividend reinvestment.

Period	AKBA	BCML
1 month	+18.42%	-8.18%
3 months	-2.17%	+1.71%
6 months	-4.26%	+5.59%
1 year	-63.11%	+17.18%
5 years(CAGR)	-11.38%	+12.81%
10 years(CAGR)	-17.23%	+10.41%
Max(CAGR)	-21.45%	+5.65%

Winner

AKBA

+18.42%

BCML

-8.18%

AKBA

-2.17%

Winner

BCML

+1.71%

AKBA

-4.26%

Winner

BCML

+5.59%

AKBA

-63.11%

Winner

BCML

+17.18%

5Y(CAGR)

AKBA

-11.38%

Winner

BCML

+12.81%

10Y(CAGR)

AKBA

-17.23%

Winner

BCML

+10.41%

Max(CAGR)

AKBA

-21.45%

Winner

BCML

+5.65%

AKBA vs BCML - Annual Returns (2004 - 2026)

Returns include dividend reinvestment.

Year	AKBA	BCML
2026	-12.90%	+6.91%
2025	-15.26%	+15.80%
2024	+49.61%	+17.46%
2023	+99.20%	+26.88%
2022	-76.45%	+2.02%
2021	-22.74%	+25.57%
2020	-55.84%	-32.88%
2019	+8.97%	+1.61%
2018	-63.06%	+18.71%
2017	+41.62%	+30.36%
2016	-17.12%	+12.15%
2015	+12.35%	+11.34%
2014	-56.40%	+22.68%
2013	N/A	+18.29%
2012	N/A	+19.71%
2011	N/A	-2.00%
2010	N/A	-9.81%
2009	N/A	+9.15%
2008	N/A	-32.38%
2007	N/A	-11.39%
2006	N/A	-1.25%
2005	N/A	-7.69%
2004	N/A	+30.00%

AKBA vs BCML Drawdown Comparison

The maximum drawdown for AKBA was -99.14%, occurring on Nov 29, 2022. This drawdown has not yet recovered.

The maximum drawdown for BCML was -62.19%, occurring on Sep 25, 2020. Recovery took 1561 trading sessions.

The current AKBA drawdown is -95.37%. The current BCML drawdown is -13.16%.

Rank	AKBA	BCML
#1	-99.14% Jun 20, 2014 - Nov 29, 2022	-62.19% Aug 23, 2018 - Nov 6, 2024
#2	-36.84% Mar 20, 2014 - Apr 21, 2014	-58.62% Oct 15, 2004 - Dec 22, 2016
#3	-21.82% Apr 21, 2014 - Jun 9, 2014	-18.03% Nov 26, 2024 - Aug 22, 2025
#4	-4.91% Jun 9, 2014 - Jun 20, 2014	-14.29% Dec 17, 2025 - Apr 9, 2026
#5	N/A	-13.59% Apr 9, 2026 - Jun 24, 2026
#6	N/A	-13.16% Jul 16, 2026 - Jul 30, 2026
#7	N/A	-11.80% Sep 18, 2025 - Dec 10, 2025
#8	N/A	-9.15% Mar 21, 2018 - May 17, 2018
#9	N/A	-6.78% Jun 4, 2018 - Aug 6, 2018
#10	N/A	-3.96% May 17, 2018 - Jun 4, 2018
#11	N/A	-3.85% Sep 15, 2004 - Sep 27, 2004
#12	N/A	-3.28% Mar 17, 2017 - Apr 24, 2017
#13	N/A	-2.69% Mar 1, 2017 - Mar 17, 2017
#14	N/A	-2.62% Aug 26, 2025 - Sep 18, 2025
#15	N/A	-2.58% Jun 27, 2017 - Sep 27, 2017

Correlation

Correlation between AKBA and BCML is -0.53 which considered as a moderate negative correlation - the stocks show some tendency to move in opposite directions.

-0.53

-101